BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29706966)

  • 1. Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.
    Migalovich Sheikhet H; Villacorta Hidalgo J; Fisch P; Balbir-Gurman A; Braun-Moscovici Y; Bank I
    Front Immunol; 2018; 9():753. PubMed ID: 29706966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-fibrotic characteristics of Vγ9+ γδ T cells in systemic sclerosis.
    Markovits N; Bendersky A; Loebstein R; Brusel M; Kessler E; Bank I
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):23-29. PubMed ID: 26886502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CD161+ Vδ1+ γδ T cells in systemic sclerosis: association with interstitial pneumonia.
    Segawa S; Goto D; Horikoshi M; Kondo Y; Umeda N; Hagiwara S; Yokosawa M; Hirota T; Miki H; Tsuboi H; Ogishima H; Suzuki T; Matsumoto I; Sumida T
    Rheumatology (Oxford); 2014 Dec; 53(12):2259-69. PubMed ID: 24972843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 conditioning of peripheral blood mononuclear cells from breast cancer patients promotes the zoledronate-induced expansion of γδ T cells in vitro and enhances their cytotoxic activity and cytokine production.
    Assy L; Khalil SM; Attia M; Salem ML
    Int Immunopharmacol; 2023 Jan; 114():109402. PubMed ID: 36481526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV/AIDS patients in vitro].
    Chen WW; Wu XL; Nie WM; Xie YX; Wang L; Zhao M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):285-7. PubMed ID: 22394638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Decreased Percentage of Vδ2
    Maimaitijiang G; Shinoda K; Nakamura Y; Masaki K; Matsushita T; Isobe N; Yamasaki R; Yoshikai Y; Kira JI
    Front Immunol; 2018; 9():748. PubMed ID: 29692781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term use of interferon-β in multiple sclerosis increases Vδ1
    Maimaitijiang G; Watanabe M; Shinoda K; Isobe N; Nakamura Y; Masaki K; Matsushita T; Yoshikai Y; Kira JI
    J Neuroinflammation; 2019 Sep; 16(1):179. PubMed ID: 31519178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Human Peripheral Blood γδ T Cells Expanded With Zoledronate.
    Kim M; Kim H; Han M; Hwang HJ; Kim H; Im HJ; Kim N; Koh KN
    Anticancer Res; 2021 Dec; 41(12):6031-6038. PubMed ID: 34848457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The comparison between HIV-infected patients' Vdelta2 T cells expansion efficiencies by zoledronic acid and gammadelta TCR monoclonal antibody in vitro].
    Xu W; Wu XL; Xie YX; Yang JL; Nie WM; Zhao M; Chen WW
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):442-5. PubMed ID: 23627025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subset-specific alterations in frequencies and functional signatures of γδ T cells in systemic sclerosis patients.
    Henriques A; Silva C; Santiago M; Henriques MJ; Martinho A; Trindade H; da Silva JA; Silva-Santos B; Paiva A
    Inflamm Res; 2016 Dec; 65(12):985-994. PubMed ID: 27576328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vgamma9+ gammadelta T cells in systemic sclerosis patients are numerically and functionally preserved and induce fibroblast apoptosis.
    Bendersky A; Markovits N; Bank I
    Immunobiology; 2010 May; 215(5):380-94. PubMed ID: 19589616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
    Giacomelli R; Matucci-Cerinic M; Cipriani P; Ghersetich I; Lattanzio R; Pavan A; Pignone A; Cagnoni ML; Lotti T; Tonietti G
    Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amplification of γδ T cells in PBMCs of healthy donors and osteosarcoma patients stimulated by zoledronate].
    Li ZX; Sun LL; Cheng RL; Sun ZW; Ye ZM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):822-4. PubMed ID: 22863589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles.
    Carbone LD; Warrington KJ; Barrow KD; Pugazhenthi M; Watsky MA; Somes G; Ingels J; Postlethwaite AE
    Clin Exp Immunol; 2006 Dec; 146(3):371-80. PubMed ID: 17100755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.
    Sugai S; Yoshikawa T; Iwama T; Tsuchiya N; Ueda N; Fujinami N; Shimomura M; Zhang R; Kaneko S; Uemura Y; Nakatsura T
    Int J Oncol; 2016 May; 48(5):1794-804. PubMed ID: 26936487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γδ T cells cultured with artificial antigen-presenting cells and IL-2 show long-term proliferation and enhanced effector functions compared with γδ T cells cultured with only IL-2 after stimulation with zoledronic acid.
    Choi H; Lee Y; Hur G; Lee SE; Cho HI; Sohn HJ; Cho BS; Kim HJ; Kim TG
    Cytotherapy; 2021 Oct; 23(10):908-917. PubMed ID: 34312069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of zoledronate on the cytotoxicity of γδ T cells from PBMCs of osteosarcoma patients against osteosarcoma].
    Li Z; Tang J; Sun L; Ye Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):6-9. PubMed ID: 23294710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
    Noguchi A; Kaneko T; Kamigaki T; Fujimoto K; Ozawa M; Saito M; Ariyoshi N; Goto S
    Cytotherapy; 2011 Jan; 13(1):92-7. PubMed ID: 20831354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma.
    Mariani S; Muraro M; Pantaleoni F; Fiore F; Nuschak B; Peola S; Foglietta M; Palumbo A; Coscia M; Castella B; Bruno B; Bertieri R; Boano L; Boccadoro M; Massaia M
    Leukemia; 2005 Apr; 19(4):664-70. PubMed ID: 15744346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses.
    Nussbaumer O; Gruenbacher G; Gander H; Komuczki J; Rahm A; Thurnher M
    J Immunol; 2013 Aug; 191(3):1346-55. PubMed ID: 23794630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.